1 Bellinda L. King-Kallimanis, PhD, LUNGevity Foundation, Bethesda, MD; Jill Feldman, MA, LungCancer Patient and Advocate and EGFR Resisters, Deerfield, IL; and Manraj Kaur, PhD, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.